The new approval means that insurance providers will likely cover the medication for people with sleep apnea and obesity.
The new approval is for people with moderate to severe obstructive sleep apnea who are also living with obesity.
The new, expanded Zepbound approval means that insurance providers, including Medicare, will likely cover the medication for people with sleep apnea and obesity. Some insurance providers, including Medicare, do not offer reimbursement to treat obesity alone. Obstructive sleep apnea isnt just an inconvenience, its a serious medical condition that impairs breathing and sleep quality. Obesity and obstructive sleep apnea are linked. People tend to see their obstructive sleep apnea get better when they lose a significant amount of weight. Its likely the weight loss associated with the medication is helping improve the sleep apnea.
In a study, people who took Zepbound had at least 25 fewer breathing interruptions per hour while they slept. They also lost an average of 20% of their body weight.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.The agency’s decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain broader insurance coverage for the treatment.
Read more »
FDA approves Eli Lilly’s obesity medication for obstructive sleep apneaIn a study, people who took Zepbound had fewer breathing interruptions.
Read more »
FDA approves Eli Lilly's obesity medication for obstructive sleep apneaThe new approval means that insurance providers will likely cover the medication for people with sleep apnea and obesity.
Read more »
FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortageThe decision that will eventually bar compounding pharmacies from making unbranded versions of the injection.
Read more »
Eli Lilly & Co. Sign Outside Corporate HeadquartersA photo of a sign for Eli Lilly & Co. outside their corporate headquarters in Indianapolis.
Read more »
FedEx, Eli Lilly, Occidental rise premarket; Nike, Novo Nordisk fallFedEx, Eli Lilly, Occidental rise premarket; Nike, Novo Nordisk fall
Read more »